Tempus Wealth Planning LLC Sells 198 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Tempus Wealth Planning LLC trimmed its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 0.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 30,694 shares of the company’s stock after selling 198 shares during the period. Tempus Wealth Planning LLC’s holdings in GE HealthCare Technologies were worth $2,400,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the stock. Mesirow Financial Investment Management Inc. grew its holdings in shares of GE HealthCare Technologies by 39.6% during the 3rd quarter. Mesirow Financial Investment Management Inc. now owns 4,084 shares of the company’s stock worth $383,000 after acquiring an additional 1,159 shares during the period. Cathy Pareto & Associates Inc. bought a new position in GE HealthCare Technologies in the fourth quarter worth $670,000. LMR Partners LLP purchased a new stake in shares of GE HealthCare Technologies in the 3rd quarter worth about $7,387,000. Principal Financial Group Inc. increased its stake in shares of GE HealthCare Technologies by 1.9% in the 3rd quarter. Principal Financial Group Inc. now owns 1,009,910 shares of the company’s stock worth $94,780,000 after acquiring an additional 19,010 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG bought a new position in shares of GE HealthCare Technologies in the 3rd quarter worth about $1,396,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of the stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the sale, the chief executive officer now owns 24,298 shares of the company’s stock, valued at approximately $2,101,291.04. This trade represents a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.27% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on GEHC shares. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company boosted their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $96.00.

View Our Latest Analysis on GE HealthCare Technologies

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $87.51 on Tuesday. GE HealthCare Technologies Inc. has a 52 week low of $72.61 and a 52 week high of $94.55. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The firm has a market cap of $39.98 billion, a P/E ratio of 24.04, a P/E/G ratio of 2.92 and a beta of 1.14. The business’s 50 day moving average price is $82.97 and its 200 day moving average price is $85.09.

GE HealthCare Technologies Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 14th will be issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.16%. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.85%.

GE HealthCare Technologies Company Profile

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Read More

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report).

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.